Literature DB >> 24803332

The association between critical illness and changes in bone turnover in adults: a systematic review.

N Orford1, C Cattigan, S L Brennan, M Kotowicz, J Pasco, D J Cooper.   

Abstract

SUMMARY: Critical illness may lead to altered bone turnover and associated adverse health outcomes. This systematic review found moderate evidence for a positive association between critical illness and increased bone turnover. Prospective cohort studies that identify the extent and risk factors for critical illness related bone loss are required.
INTRODUCTION: Intensive care patients face health issues that extend beyond their critical illness and result in significant morbidity and mortality. Critical illness may result in altered bone turnover due to associated immobilisation, inflammation, exposure to medications that effect bone and calcium metabolism, and endocrine dysfunction. The aim of this study was to synthesise the existing evidence for altered bone turnover in adults admitted to intensive care.
METHODS: A literature search using MEDLINE and EMBASE was performed from 1965 to March 2013. Reviewed studies investigated the relationship between critical illness and evidence of altered bone turnover (bone turnover markers, bone mineral density, or fracture). Studies were rated upon their methodological quality, and a best-evidence synthesis was used to summarise the results.
RESULTS: Four cohort and seven case-control studies were identified for inclusion, of which five studies were rated as being of higher methodological quality. Ten of the studies measured bone turnover markers, and one study fracture rate. Findings were consistent across studies, and best-evidence analysis resulted in a conclusion that moderate evidence exists for an association between critical illness requiring admission to intensive care and altered bone turnover.
CONCLUSION: A positive association between critical illness requiring intensive care admission and bone turnover exists, although data are limited, and the risk factors and the nature of the relationship are not yet understood. Prospective cohort studies that identify risk factors and extent of critical illness related bone turnover changes are required.

Entities:  

Mesh:

Year:  2014        PMID: 24803332     DOI: 10.1007/s00198-014-2734-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  43 in total

1.  Surviving intensive care: a report from the 2002 Brussels Roundtable.

Authors:  Derek C Angus; Jean Carlet
Journal:  Intensive Care Med       Date:  2003-01-21       Impact factor: 17.440

2.  High-sensitivity C-reactive protein and fracture risk in elderly women.

Authors:  Julie A Pasco; Mark A Kotowicz; Margaret J Henry; Geoffrey C Nicholson; Heather J Spilsbury; Jeffrey D Box; Hans G Schneider
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

3.  Bone loss during critical illness: a skeleton in the closet for the intensive care unit survivor?

Authors:  David M Griffith; Tim S Walsh
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

4.  Urinary pyridinium cross-link excretion is increased in critically ill surgical patients.

Authors:  S A Shapses; C Weissman; M J Seibel; H A Chowdhury
Journal:  Crit Care Med       Date:  1997-01       Impact factor: 7.598

5.  Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness.

Authors:  Michael A Via; Matthew V Potenza; Jason Hollander; Xuan Liu; Yuanzhen Peng; Jianhua Li; Li Sun; Mone Zaidi; Jeffrey I Mechanick
Journal:  J Intensive Care Med       Date:  2011-03-24       Impact factor: 3.510

6.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 7.  Endocrine and metabolic issues in the management of the chronically critically ill patient.

Authors:  Jeffrey I Mechanick; Elise M Brett
Journal:  Crit Care Clin       Date:  2002-07       Impact factor: 3.598

Review 8.  Bisphosphonates and metabolic bone disease in the ICU.

Authors:  Jason M Hollander; Jeffrey I Mechanick
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-03       Impact factor: 4.294

9.  Long-term outcome of critically ill elderly patients requiring intensive care.

Authors:  L Chelluri; M R Pinsky; M P Donahoe; A Grenvik
Journal:  JAMA       Date:  1993 Jun 23-30       Impact factor: 56.272

10.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

Authors:  Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis
Journal:  Clin Chem Lab Med       Date:  2011-05-24       Impact factor: 3.694

View more
  8 in total

Review 1.  Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Authors:  P Szulc; K Naylor; N R Hoyle; R Eastell; E T Leary
Journal:  Osteoporos Int       Date:  2017-06-19       Impact factor: 4.507

2.  The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.

Authors:  E Cavalier; P Bergmann; O Bruyère; P Delanaye; A Durnez; J-P Devogelaer; S L Ferrari; E Gielen; S Goemaere; J-M Kaufman; A Nzeusseu Toukap; J-Y Reginster; A-F Rousseau; S Rozenberg; A J Scheen; J-J Body
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

3.  Evaluation of Bone Metabolism in Critically Ill Patients Using CTx and PINP.

Authors:  Alexandra Gavala; Konstantinos Makris; Anna Korompeli; Pavlos Myrianthefs
Journal:  Biomed Res Int       Date:  2016-11-29       Impact factor: 3.411

4.  The association of time and medications with changes in bone mineral density in the 2 years after critical illness.

Authors:  Neil R Orford; Michael Bailey; Rinaldo Bellomo; Julie A Pasco; Claire Cattigan; Tania Elderkin; Sharon L Brennan-Olsen; David J Cooper; Mark A Kotowicz
Journal:  Crit Care       Date:  2017-03-21       Impact factor: 9.097

Review 5.  Bone function, dysfunction and its role in diseases including critical illness.

Authors:  Nan Su; Jing Yang; Yangli Xie; Xiaolan Du; Hangang Chen; Hong Zhou; Lin Chen
Journal:  Int J Biol Sci       Date:  2019-01-29       Impact factor: 6.580

6.  Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.

Authors:  Ryosuke Tokida; Masashi Uehara; Masaki Nakano; Takako Suzuki; Noriko Sakai; Shota Ikegami; Jun Takahashi; Yukio Nakamura; Hiroyuki Kato
Journal:  Sci Rep       Date:  2021-04-09       Impact factor: 4.379

Review 7.  Critical illness and bone metabolism: where are we now and what is next?

Authors:  Yun Cai; Fuxin Kang; Xiaozhi Wang
Journal:  Eur J Med Res       Date:  2022-09-14       Impact factor: 4.981

Review 8.  Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa.

Authors:  K Amrein; A Papinutti; E Mathew; G Vila; D Parekh
Journal:  Endocr Connect       Date:  2018-12-01       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.